Are Blood Plasma Treatments Due for a Revolution?
Dr Trevor Castor is the President of Aphios International, a name that means “virus-free” in Greek. “We are developing a pathogen-reduction technology called CFI to clear blood plasma, plasma products, biologics and medical devices of viruses and other pathogens. Our technology is unique in that it does not use heat, chemicals or radiation that could be harmful…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Get featured
Want to get featured in MarketScale Healthcare?
Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.
Dr Trevor Castor is the President of Aphios International, a name that means “virus-free” in Greek.
“We are developing a pathogen-reduction technology called CFI to clear blood plasma, plasma products, biologics and medical devices of viruses and other pathogens.
Our technology is unique in that it does not use heat, chemicals or radiation that could be harmful to the underlying beneficial proteins, such as antibodies.
Our technology works by giving the virus the bends. [We put] virus particles with a gas under pressure, then quickly release the pressure, and the infected virus pops at the weakest points, very much like the disruption of a scuba diver who rises too rapidly or the popping of a balloon.
Our research, funded by the National Institutes of Health, has been successful, and we are [continually] raising funds.”
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
